A Pilot Study to Test Multiple Medication Usage and Driving Functioning
archive: archived pipeline: cataloged verified
Get this paper ↗ (full text — opens at the source; we link to it, we don't host it)
Summary
This pilot study, conducted by TransAnalytics, LLC for the National Highway Traffic Safety Administration (NHTSA), investigates the relationship between polypharmacy—specifically the use of multiple potentially driver-impairing (PDI) medications—and driving functioning in older adults. The research was motivated by the growing population of older drivers, who face higher crash fatality rates and increased prevalence of chronic conditions requiring medication. The study aimed to identify trends in PDI medication exposure, evaluate specific drug effects on driving, and determine feasible methodologies for future large-scale research. The project employed a multi-phase approach. First, researchers conducted a literature review to update knowledge on specific drug classes, including opioids, sedatives, and antidepressants, and their impact on driving and fall risk. Second, they mined the PharMetrics administrative claims database, which contained prescription data and injury codes for over 133,000 individuals, to identify PDI medication combinations associated with motor vehicle crashes. This analysis revealed that crash-involved drivers aged 50 and older frequently used combinations of hypotensives with other PDI drugs. Third, a field study was conducted with 44 older adults (ages 57–89) who met inclusion criteria based on the database findings. Participants underwent functional screening, pharmacist-led "brown bag" medication reviews, and on-road driving evaluations by an occupational therapist. The evaluations utilized an instrumented vehicle equipped with GPS, speed sensors, and video cameras to measure brake response time and driving behavior. A subsample of five participants also drove their private vehicles independently for one week to compare behavior against the formal evaluation context. The results indicated that while logistic regression could not significantly associate medication usage with driving outcomes due to the small sample size, drivers who failed the occupational therapy evaluation were among the oldest participants, suggesting age-related physiological changes may exacerbate medication impairment. Notably, ACE inhibitors and ACE inhibitor/thiazide diuretic combinations were identified as areas requiring further attention. The comparison between independent driving and formal evaluations revealed significant behavioral variability; drivers spent more time looking inside the vehicle and less at the rearview mirror when driving alone. One case study showed an 82-year-old participant drove slower in traffic but faster on empty roads during independent driving compared to the supervised evaluation. The study concludes that small-sample empirical investigations are impractical for modeling the complex relationships between multiple medications and driving impairment due to recruitment difficulties and low prevalence of specific drug combinations in general populations. Instead, the authors recommend future research utilize large administrative claims databases, such as the Ingenix LabRx or Veteran’s Health Administration databases, to identify high-risk drug combinations. Additionally, they advocate for the use of unobtrusive, in-car instrumentation to monitor drivers' behavior in naturalistic settings, allowing for the assessment of behavioral variability and normative exposure to risk factors. These findings support the development of targeted interventions and individualized medication reviews to enhance safety for older drivers.
Key finding
Small-sample empirical investigations were unable to significantly associate medication usage with driving performance outcomes, leading to the conclusion that large administrative databases and unobtrusive in-car instrumentation are more practical strategies for future research on polypharmacy and driving.
Methodology
mixed_methods
Sample size: 44
Provenance
The full processing record for this entry. Every stage of this paper's journey through the pipeline is logged — what ran, with which tool and model, how many attempts it took, and when it last completed. Discovered via bulk_ingest_rosap on 2026-05-23 (6 acquisition events logged).
| Stage | Outcome | Tool | Model | Prompt | Attempts | Completed |
|---|---|---|---|---|---|---|
| discover | success | rosap | — | — | 2 | 2026-05-23 |
| archive | success | — | — | — | 1 | 2026-05-23 |
| extract | success | cached | — | — | 2 | 2026-06-10 |
| clean | success | — | — | — | 1 | 2026-06-01 |
| chunk | success | — | — | — | 1 | 2026-06-01 |
| embed | success | — | — | — | 1 | 2026-06-02 |
| enrich | success | — | — | — | 1 | 2026-05-23 |
| promote | success | — | — | — | 1 | 2026-05-23 |
| summarize | success | llm | qwen3.6-27b-prismaquant | summ-v5 | 3 | 2026-06-10 |
| tag | success | vector_similarity | — | — | 19 | 2026-06-11 |
| verify | success | — | — | — | 2 | 2026-06-10 |
Summary generated by qwen3.6-27b-prismaquant on 2026-06-10; verification: verified.
Topics
Ranked by relevance to this paper. Hover a topic for its definition.
Information type
What kind of knowledge this paper contributes, grouped by family — independent of topic (what it is about) and method (how it was studied).
- Empirical Findings: observational prevalence, crash risk outcomes
- Methodological Resource: dataset resource